Based in Basle, she will work in a team of five and will specialise in comms around oncology, research & development and diagnostics, excluding diabetes products.
Schmitt previously held the same title at Roche’s rival Bayer Schering Pharma in Berlin, where she worked on pharma products and corporate PR. A former student of chemistry and biochemistry, she reports to Roche head of R&D comms Katja Prowald.
Daniel Piller is overall head of the PR office, which handles international media enquiries. One of Roche’s most high profile drugs is flu pandemic vaccine Tamiflu, for which Ketchum landed the global account this year (PRWeek, 2 May).